Hook & thesis
Cameco Corporation is a leading uranium producer whose shares have pulled back to the mid-$90s after a Q2 earnings miss driven mainly by lower equity earnings from its Westinghouse investment. That weakness is an opportunity: Westinghouse is being prepared for an IPO and recent commentary implies the timetable has shortened. If Westinghouse comes to market sooner rather than later, Cameco’s 49% stake is an obvious source of near-term upside and multiple expansion.
We are upgrading CCJ to a tactical long. This is not a buy-and-forget macro play—it's a catalyst-driven trade: enter on weakness, give the position time through the likely IPO window, and define risk tightly. The trade plan below targets upside from current levels to a meaningful re-rating while protecting capital if the IPO is delayed or uranium spot prices swing lower.
Why the market should care
Cameco is not a niche miner. The company operates across the uranium value chain - exploration, mining, milling and fuel services - and it benefits from both commodity exposure and an industrial-service leg via its Westinghouse stake. Market cap sits at $41,062,051,240, shares outstanding are 435,533,000, and the stock trades at $94.28 today with a 52-week range of $68.96 to $135.24.
Two themes matter for investors: (1) supply/demand tightness for uranium amid a global nuclear renaissance, and (2) corporate optionality from Westinghouse. The market’s narrative has shifted toward nuclear as an enabler of decarbonization and a stable baseload for AI-heavy data centers. Separately, Cameco’s Westinghouse stake is a different kind of value that an IPO would crystallize for public investors.
Fundamentals in brief - what the numbers say
- Market cap: $41.06B; shares outstanding: 435.53M.
- Trading metrics: P/E ~167.6, P/B ~8.54 - valuation is premium by traditional mining metrics, reflecting growth expectations and asset optionality.
- Dividend yield: ~0.17%; Cameco is not a yield play.
- Price action: current $94.28 vs 10-day SMA $96.87, 20-day SMA $92.73, and 50-day SMA $96.24. Momentum indicators show bullish tilt - MACD line 0.788 vs signal -0.123 (bullish momentum) while RSI is neutral at 48.9.
- Short interest: 7,121,402 shares as of 07/31/2026 with days to cover ~1.68, and recent short-volume data shows sizable short activity in mid-August—this increases potential volatility around catalysts.
What happened with Q2
On 08/08/2026 Cameco reported an earnings miss with revenue down ~7% and EPS below estimates; management attributed much of the shortfall to lower equity earnings from Westinghouse rather than an operational collapse in uranium mining. The market punished the stock on that miss, but that same disclosure sharpened the focus on Westinghouse as the variable that will determine near-term upside.
Valuation framing
At ~$41.1B market cap and a price in the mid-$90s, Cameco already reflects substantial future growth expectations. On simple logic: if Westinghouse’s valuation has risen from CA$8.2B at acquisition to CA$10.8B more recently, Cameco’s 49% stake implies several billion in incremental value that is currently embedded but not liquid. That embedded Westinghouse value, combined with sustained uranium demand, supports a re-rating if and when the IPO establishes a market price for Westinghouse.
That said, the current P/E of ~167.6 is stretched versus commodity peers, which is why we frame this as a tactical, catalyst-driven trade rather than a long-term buy-and-hold thesis without active monitoring.
Catalysts
- Westinghouse IPO talk becoming real - public offering or formal valuation event that crystallizes Cameco’s stake value.
- Q3 results and management commentary providing clarity on Westinghouse equity earnings and long-term contract wins for nuclear services.
- Improving spot uranium prices and contracting activity that would lift Cameco’s uranium economics.
- Macro energy moves such as new nuclear deals or policy support (e.g., international agreements) that accelerate nuclear build-out.
Trade plan (actionable)
We recommend a tactical long into the Westinghouse IPO window with clearly defined entry, stop and target. This is a mid-term catalyst play:
| Item | Detail |
|---|---|
| Entry Price | $94.00 |
| Stop Loss | $88.00 |
| Target Price | $110.00 |
| Horizon | mid term (45 trading days) - allow time for IPO announcement or Q3 commentary to materialize |
| Risk Level | Medium |
Rationale: $94.00 sits just below the current market price and under recent short-term moving averages, giving a tactical entry after the post-earnings relief move fizzled. The $110 target is a roughly 17% gain from entry and is conservative relative to the stock's 52-week high of $135.24—appropriate if Westinghouse IPO valuation and better-than-expected equity earnings boost sentiment. The $88 stop caps downside at ~6% from entry, balancing room for normal volatility with disciplined capital protection.
Risks & counterarguments
- Westinghouse IPO could be delayed or priced conservatively. If the IPO is pushed beyond the mid-term window or comes in at a lower-than-expected valuation, any re-rating for Cameco will be delayed or muted. This is the trade’s primary execution risk.
- Commodity risk - uranium price weakness. A fall in spot uranium or slower contracting by utilities would pressure Cameco’s underlying mining economics and could erase the multiple expansion from Westinghouse news.
- Operational/earnings risk. Cameco’s Q2 miss showed equity earnings volatility linked to Westinghouse. Continued misses or mining disruptions would be negative for the stock.
- Valuation vulnerability. The current P/E ~167.6 and P/B ~8.5 suggest a lot of growth expectations are priced in; any disappointment risks a sharp re-rating downward. High short activity increases the risk of whipsawing price action.
- Regulatory/political risks. Nuclear energy projects face long timelines and political scrutiny. Shifts in policy in major markets could change demand forecasts for uranium and nuclear services.
Counterargument: A reasonable opposing view is that Cameco is already priced for perfection on the Westinghouse option and for rising nuclear demand; with a stretched P/E, the path to $110 (our target) may be narrow unless the IPO is both timely and compelling. Put differently, there’s a credible scenario where Westinghouse is valued conservatively, uranium prices stagnate, and CCJ trades sideways or lower. That’s why the trade uses a tight stop and a mid-term horizon rather than an open-ended hold.
Why this trade, not buy-and-hold
This is a play on a discrete corporate event - an IPO that can unlock latent value - rather than a pure long-term commodity bet. If you want long-term exposure to uranium and nuclear services without event risk, consider a dollar-cost-averaging approach or diversified ETF exposure to the sector. For active traders who can tolerate mid-term volatility, the IPO window creates an asymmetric payoff: downside is limited with a defined stop, upside is multiple-driven and therefore larger.
What would change my mind
- If Westinghouse files and prices an IPO within the next 45 trading days at valuation levels implying less than a $2-3B uplift to Cameco’s net equity value, I would reassess the trade and likely close the position.
- If Cameco reports another quarter of weak equity earnings from Westinghouse and provides guidance that suggests multi-quarter headwinds, I would tighten stops or exit.
- Conversely, if spot uranium and contracting improve materially alongside a firm IPO timetable, I would increase conviction and consider adding to the position toward $100 on strength.
Conclusion
Cameco is an attractive tactical long right now because recent weakness understates the immediate optionality coming from a likely Westinghouse IPO and understates the structural demand tailwinds for uranium. We recommend entering at $94.00 with a stop at $88.00 and a target of $110.00, over a mid-term horizon of 45 trading days, realizing this trade hinges on the timing and reception of the Westinghouse IPO and on uranium market dynamics.
Trade summary: Buy CCJ at $94.00, stop $88.00, target $110.00, mid term (45 trading days). Manage position size and be ready to react to IPO timing and quarterly updates.